In addition, the expression levels and frequencies of PLK1 were higher in stages 2–4 than those of stage 1 of adenocarcinoma and squamous cell carcinoma (Fig. 1a and Supplementary Fig. S1), indicating that PLK1 is highly expressed in metastatic NSCLC. This evidence concerns the gene PLK1 and non-small cell lung carcinoma.